全文获取类型
收费全文 | 36480篇 |
免费 | 2850篇 |
国内免费 | 430篇 |
专业分类
耳鼻咽喉 | 368篇 |
儿科学 | 1048篇 |
妇产科学 | 637篇 |
基础医学 | 5290篇 |
口腔科学 | 558篇 |
临床医学 | 3495篇 |
内科学 | 7845篇 |
皮肤病学 | 801篇 |
神经病学 | 2715篇 |
特种医学 | 1373篇 |
外国民族医学 | 16篇 |
外科学 | 4451篇 |
综合类 | 1312篇 |
现状与发展 | 1篇 |
一般理论 | 4篇 |
预防医学 | 2937篇 |
眼科学 | 751篇 |
药学 | 2763篇 |
6篇 | |
中国医学 | 635篇 |
肿瘤学 | 2754篇 |
出版年
2023年 | 294篇 |
2022年 | 714篇 |
2021年 | 1189篇 |
2020年 | 748篇 |
2019年 | 925篇 |
2018年 | 1141篇 |
2017年 | 816篇 |
2016年 | 804篇 |
2015年 | 966篇 |
2014年 | 1250篇 |
2013年 | 1611篇 |
2012年 | 2329篇 |
2011年 | 2338篇 |
2010年 | 1439篇 |
2009年 | 1190篇 |
2008年 | 1740篇 |
2007年 | 1771篇 |
2006年 | 1717篇 |
2005年 | 1614篇 |
2004年 | 1420篇 |
2003年 | 1353篇 |
2002年 | 1278篇 |
2001年 | 1158篇 |
2000年 | 1163篇 |
1999年 | 1011篇 |
1998年 | 360篇 |
1997年 | 318篇 |
1996年 | 272篇 |
1995年 | 224篇 |
1994年 | 210篇 |
1993年 | 184篇 |
1992年 | 537篇 |
1991年 | 516篇 |
1990年 | 487篇 |
1989年 | 444篇 |
1988年 | 466篇 |
1987年 | 394篇 |
1986年 | 380篇 |
1985年 | 380篇 |
1984年 | 265篇 |
1983年 | 194篇 |
1982年 | 124篇 |
1981年 | 107篇 |
1979年 | 219篇 |
1978年 | 118篇 |
1977年 | 127篇 |
1976年 | 117篇 |
1974年 | 136篇 |
1972年 | 130篇 |
1969年 | 105篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
C. Bourdeaux A. Darwish J. Jamart T.T. Tri M. Janssen J. Lerut J.-B. Otte E. Sokal J. de Ville de Goyet R. Reding 《American journal of transplantation》2007,7(2):440-447
Timely access to a living donor (LD) reduced pretransplant mortality in pediatric liver transplantation (LT). We hypothesized that this strategy may provide better posttransplant outcome. Between July 1993 and April 2002, 235 children received a primary LT from a LD (n = 100) or a deceased donor (DD) (n = 135). Demographic, surgical and immunological variables were compared, and respective impact on posttransplant complications was studied using a multivariate analysis. Five-year patient survival rates were 92% and 85% for groups LD and DD, respectively (p = 0.181), the corresponding graft survival rates being 89% and 77% (p = 0.033). At multivariate analysis: (1) type of donor (DD) was correlated with higher rate of artery thrombosis (p < 0.012); (2) biliary complication rate at 5 years was 29% and 23% for groups LD and DD, respectively (p = 0.451); (3) lower acute rejection incidence could be correlated with type of donor (DD) (p = 0.001), and immunosuppressive therapy (tacrolimus) (p < 0.001). We conclude that (1) according to the multivariate analysis, LT with LD provided similar patient and graft outcome, when compared to DD; (2) a higher rate of artery thrombosis and a lower rate of rejection were observed in group DD; (3) this study confirms the efficacy of tacrolimus for immunoprophylaxis, whatever the type of organ donor is. 相似文献
82.
G G Varela A López-Loredo J F García León 《JSLS, Journal of the Society of Laparoendoscopic Surgeons》2007,11(1):127-130
BACKGROUND AND OBJECTIVE: We present the case of a female patient 29 years of age with antecedents of laparoscopic laser ablation for endometriosis, laparoscopic appendectomy, and umbilical hernioplasty. METHODS: The patient was admitted to the hospital's emergency room for abdominal pain in the epigastrium, transfixing, irradiating to both upper quadrants and to the lumbar region, accompanied by nausea and gastrobiliary vomiting. Lipase determination was 170 mg/dL. Other laboratory findings were normal. Plain abdominal films on the patient's admission were normal, and computed tomography (CT) showed data compatible with acute pancreatitis. Without improvement during the patient's hospital stay, pain and vomiting increased in intensity and frequency. RESULTS: New abdominal x-rays revealed dilatation of small bowel loops. Management was begun for intestinal obstruction, with intravenous hydration and placement of a nasogastric tube without a good response. At 48 hours, a diagnostic laparoscopy was performed, revealing a 3-cm internal hernia in the left broad ligament in which a 20-cm segment of terminal ileum was encased. We performed liberation of the ileal segment and closed the hernial orifice by using the laparoscopic approach. CONCLUSION: The patient's evolution was excellent. 相似文献
83.
Thellea K. Leveque Le Yu David C. Musch Ronald D. Chervin David N. Zacks 《Sleep & breathing》2007,11(4):253-257
Patients with obstructive sleep apnea (OSA), in comparison to controls, have increased levels of circulating epinephrine and
norepinephrine, both of which are risk factors for the development of central serous chorioretinopathy (CSCR). The aim of
this pilot study was to investigate the frequency of symptoms that suggest OSA in CSCR patients and normal controls. The Berlin
Questionnaire, a validated research tool to assess risk for OSA, was administered to 29 patients who met the criteria for
active, acute, non-steroid-induced CSCR and 29 controls matched for age and sex. In this retrospective case-controlled study,
the main outcome measure was increased risk for OSA. The mean age of the patients was 47.8 years (range 29–72) and the mean
age of controls was 47.3 years (range 25–70). Seventy-six percent (22) of both groups were men. Survey scores showed 58.6%
(17) of patients with CSCR to be at an increased risk for OSA compared to 31.0% (nine) of controls. A conditional logistic
regression analysis showed that the CSCR group had a higher proportion with an increased risk for OSA compared to the control
group (odds ratio=3.67; 95% CI: 1.02, 13.14; P = 0.046). Patients with CSCR may be more likely than other adults to have OSA, and screening for this sleep disorder should
be considered in this population. Further research is warranted to determine whether sleep apnea may contribute to the development
of CSCR, and to assess whether treatment of sleep apnea might offer a new therapeutic option for some patients with CSCR. 相似文献
84.
Vanessa Vu J. Carl Barrett Joseph Roycroft Loretta Schuman David Dankovic Paul BBaro Ted Martonen William Pepelko David Lai 《Regulatory toxicology and pharmacology : RTP》1996,24(3):202-212
On May 8–10, 1995, a workshop on chronic inhalation toxicity and carcinogenicity testing of respirable fibrous particles was held in Chapel Hill, North Carolina. The workshop was sponsored by the Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency (EPA), in collaboration with the National Institute of Environmental Health Sciences (NIEHS), the National Institute for Occupational Safety and Health (NIOSH), and the Occupational Safety and Health Administration (OSHA). The goal of the workshop was to obtain input from the scientific community on a number of issues related to fiber testing. Major issues for discussion were: (i) the optimal design and conduct of studies of the health effects of chronic inhalation exposure of animals to fibers; (ii) preliminary studies which would be useful guides in designing the chronic exposure study; (iii) mechanistic studies which would be important adjuncts to the chronic exposure study to enable better interpretation of study results and extrapolation of potential effects in exposed humans; and (iv) available screening tests which can be used to develop a minimum data set for (a) making decisions about the potential health hazard of the fibers and (b) prioritizing the need for further testing in a chronic inhalation study. After extensive discussion and debate of the workshop issues, the general consensus of the expert panel is that chronic inhalation studies of fibers in the rat are the most appropriate tests for predicting inhalation hazard and risk of fibers to humans. A number of guidances specific for the design and conduct of prechronic and chronic inhalation studies of fibers in rodents were recommended. For instance, it was recommended that along with other information (decrease in body weight, systemic toxicity, etc.), data should be obtained on lung burdens and bronchoalveolar lavage fluid analysis to assist in establishing the chronic exposure levels. Lung burden data are also important for quantifying aspects of risk assessment related to dosimetric adjustments before extrapolation. Although mechanistic studies are not recommended as part of the standard chronic inhalation studies, the expert panel stressed the need for obtaining mechanistic information as far as possible during the course of subchronic or chronic inhalation studies. At present, no single assay and battery of short-term assays can predict the outcome of a chronic inhalation bioassay with respect to carcinogenic effects. Meanwhile, several short-termin vitroandin vivostudies that may be useful to assess the relative potential of fibrous substances to cause lung toxicity/carcinogenicity have been identified. 相似文献
85.
86.
87.
Prospective study of the occurrence of monoclonal gammapathies following bone marrow transplantation in young children 总被引:2,自引:0,他引:2
We have prospectively studied the occurrence of monoclonal serum immunoglobulins in 38 recipients of BMT. Patients were young children with primary immunodeficiencies (n = 31), other inherited diseases (n = 4), leukemia (n = 2), or aplastic anemia (n = 1). Twenty-nine received an HLA-nonidentical marrow and nine an HLA-identical marrow. Serum monoclonal immunoglobulins were detected by the immunofixation method. Monoclonal immunoglobulins were found in 26 patients. Monoclonal components were more frequently detected in patients with primary severe T cell deficiencies (21/25) rather than in the other patients (6/13). In 7 of 29 recipients of HLA-nonidentical transplants, versus 0 out of 9 recipients of HLA-identical transplants, serum monoclonal immunoglobulins were found associated with a B lymphocyte proliferation syndrome due to an Epstein-Barr virus infection. In this group, monoclonal immunoglobulins were detected early, prior to the onset of the clinical syndrome. The simultaneous occurrence of several monoclonal immunoglobulins was more frequent in these patients, while monoclonal immunoglobulin concentrations increased faster, especially those of IgM isotype. These characteristics may allow in patients at risk (recipients with primary T cell immunodeficiencies and receiving HLA-nonidentical transplantation) an earlier diagnosis of B lymphocyte proliferative syndrome that may eventually lead to early and more efficient therapy. 相似文献
88.
89.
D Komiotis C T Lim J P Dieter G C Le Breton D L Venton 《Journal of medicinal chemistry》1992,35(16):3033-3039
Previous observations implicating PgH2 as a direct activator of platelets suggested that derivatives of U46619, a well-characterized TxA2 receptor agonist having structural homology with PgH2, might possess antiplatelet activity. The present work describes the synthesis of [1S-(1 alpha,2 beta,3 alpha,4 alpha)]-3-[(tetrahydropyranyloxy)methyl]- 2-[2-[(triphenylmethyl)oxy]ethyl]-5-oxabicyclo[2.2.1]heptane (14) a potentially useful intermediate for the synthesis of various epoxymethano derivatives. The latter was converted to [1S-(1 alpha,2 beta (Z),3 alpha,4 alpha)]-7-[3-[[2- [(phenylamino)carbonyl]-hydrazino]methyl]-5-oxabicylo[2.2.1]hept-2 - yl]-5-heptenoic acid (23), an epoxymethano derivative of PgH2 containing a hydrazide lower side chain as previously used in the TxA2 antagonist, SQ 29,548. The intermediate 14 was also converted to [1S-(1 alpha,2 beta (Z),3 alpha,4 alpha)]-7- [3-[(hexylamino)methyl]-5-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid (25) which contained a simple aza side chain as used in earlier antagonists. Derivatives 23 and 25 appeared to be specific antagonists of the human platelet TxA2 receptor as evidenced by their inhibition of U46619 (1.5 microM) induced aggregation of human platelet rich plasma (IC50 = 22 and 7 microM, respectively), while having little effect on ADP (2 microM) induced aggregation at much higher concentrations. In addition, one of these derivatives, the bicycloamine 25, was shown to compete for [3H]U46619 binding to washed human platelets with an IC50 value of 25 microM, supporting the notion that these derivatives were acting at the thromboxane receptor. However, the potency of these derivatives was less than for previously reported TxA2 antagonists, suggesting that simple linear combinations of functionality from molecules active at the human platelet thromboxane receptor will be of limited predictive value. 相似文献
90.
乳腺癌患者血中角蛋白mRNA基因的表达 总被引:1,自引:0,他引:1
目的 分析乳腺癌患者外周血液中角蛋白(CK19)mRNA基因的表达。方法 取20例经病理证实的乳腺癌患者外周血,用Tirizol法提取总RNA,然后进行RT-PCR荧光定量检测,并与正常人群进行对照。结果 正常人群外周血中无CK19表达,20例乳腺癌中有6例阳性表达,总阳性率为29.65%,其中单纯癌阳性率为30.7%(4/13),浸润性导管癌阳性率为28.6%(2/7)。结论 CK19可作为检测外周血循环癌细胞的标志物。 相似文献